BeStock  
Stocks › Biotechnology › LGND

Ligand Pharmaceuticals LGND

US equityMarket cap rank #1897Biotechnology
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership117.7%+1.57 pts vs. prior quarter
Institutions holding495+10 vs. prior quarter
Insider trades (recent)18 buys / 32 sellsNet selling
Short interest12.36% of floatDays to cover 10.5 · as of 30 Oct 2026
Short-sale volume share18.1%5-day average of daily volume

Short-sale volume as % of daily volume

10%16%23%30%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$13.34M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$9.4MSuper−$3.9MBig−$9.1MMid−$9.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.8% of shares outstanding.

Largest holders

  • BlackRock15.56%
  • Invesco Ltd.5.87%
  • Vanguard Portfolio Management, LLC5.56%
  • Janus Henderson Group plc5.20%
  • Franklin Resources4.56%
  • Vanguard Capital Management, LLC4.35%
  • State Street Global Advisors4.17%
  • FMR3.49%

By investor type

  • Mutual Fund108.74%
  • Public Company4.02%
  • Individual/Insider2.23%
  • Government Pension Fund1.92%
  • Hedge Fund1.56%
  • Private Company0.90%
  • Family Office/Trust0.27%
  • Insurance Company0.24%

Reported short interest has risen from 12.28% to 12.36% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Invesco Ltd. Mutual Fund 2026/Q3 +246,583 5.9%
Franklin Resources Mutual Fund 2026/Q3 +160,267 4.6%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +118,466 0.6%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +72,684 1.7%
Citigroup Inc. Public Company 2026/Q3 +63,349 0.6%
Telemark Asset Management, LLC Hedge Fund 2026/Q3 +50,000 0.2%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +49,785 0.9%
UBS Asset Management Mutual Fund 2026/Q3 +46,510 1.9%
BMO Asset Management Mutual Fund 2026/Q3 +46,405 0.3%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +34,866 0.5%
Invesco Ltd. Mutual Fund 2026/Q3 +369,714 4.7%
Neuberger Berman Investment Advisers LLC Mutual Fund 2026/Q3 +246,893 1.2%
FMR Mutual Fund 2026/Q3 +166,563 3.8%
Putnam LLC Mutual Fund 2026/Q3 +158,546 0.8%
Congress Asset Management Company, LLP Mutual Fund 2026/Q3 +155,274 3.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 John Kozarich Independent Chairperson Intent to Sell (Form 144) -500 $325.00 –
11 Nov 2026 Martine Zimmermann Independent Director Intent to Sell (Form 144) -2,000 $318.17 –
10 Nov 2026 John Kozarich Independent Chairperson Intent to Sell (Form 144) -500 $317.32 –
9 Nov 2026 Jason Aryeh Independent Director Open Market Disposition -3,000 $320.20 104,640
3 Nov 2026 Jason Aryeh Independent Director Open Market Disposition -282 $319.99 107,640
1 Nov 2026 Jason Aryeh Independent Director Intent to Sell (Form 144) -700 $316.56 –
1 Nov 2026 Andrew Reardon Chief Legal Officer Derivative Exercise and Sale -5,000 $323.14 31,854
1 Nov 2026 Jason Aryeh Independent Director Open Market Disposition -2,111 $320.49 107,922
29 Oct 2026 Jason Aryeh Independent Director Intent to Sell (Form 144) -1,209 $318.60 –
29 Oct 2026 Jason Aryeh Independent Director Intent to Sell (Form 144) -202 $320.49 –
1 Oct 2026 Andrew Reardon Chief Legal Officer Automatic Disposition -4,660 $307.74 31,854
1 Oct 2026 Andrew Reardon Chief Legal Officer Derivative Exercise and Sale -340 $302.51 31,854
21 Sep 2026 Martine Zimmermann Independent Director Sale to Issuer -115 $298.50 2,946
9 Sep 2026 Martine Zimmermann Independent Director Open Market Disposition -1,200 $285.00 3,061
2 Sep 2026 Andrew Reardon Chief Legal Officer Automatic Disposition -5,000 $288.98 36,514
11 Aug 2026 Jason Haas Independent Director Open Market Disposition -1,000 $292.81 3,145
11 Aug 2026 Jason Haas Independent Director Derivative Exercise and Sale -6,138 $292.81 3,145
11 Aug 2026 Octavio Espinoza Chief Financial Officer Derivative Exercise and Sale -31,641 $292.07 27,696
2 Aug 2026 Andrew Reardon Chief Legal Officer Derivative Exercise and Sale -5,000 $292.82 41,514
30 Jun 2026 Andrew Reardon Chief Legal Officer Derivative Exercise and Sale -5,000 $317.15 41,514

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,464,093 12.4% 10.5
15 Oct 2026 2,501,915 12.5% 10.5
30 Sep 2026 2,677,998 13.4% 8.7
15 Sep 2026 2,632,434 13.2% 13.5
31 Aug 2026 2,480,981 12.4% 14.1
14 Aug 2026 2,448,076 12.3% 8.8

Discussion

No comments yet — be the first to weigh in on LGND.

Sign in to join the discussion.

Scroll to Top